Spectral Diagnostics Inc. announced that the 29th International Symposium on Intensive Care and Emergency Medicine in Belgium, will feature a key scientific symposium entitled, “The Role of Endotoxin”, that will include presentations from six thought leaders in the field of sepsis. Presentations will include topics such as defining the role that endotoxin plays in sepsis and organ dysfunction; using Spectral’s Endotoxin Activity Assay (EAA) to determine optimum management of patients with intra-abdominal infections; and, the role of diagnosing and treating endotoxemia in patients with severe sepsis and septic shock. “The prominence given to endotoxin at this significant international conference reflects the increased recognition within the critical care community of its role in sepsis,” said Dr. Paul Walker, President and CEO of Spectral Diagnostics. “Results presented at this conference highlight the efficacy of our EAA in identifying patients most likely to benefit from anti-endotoxin therapies and the effectiveness of the Toraymyxin product to remove endotoxin and improve patient outcomes.”